Clinicopathological profile of ameloblastoma
A retrospective study for 5-years
Keywords:
Ameloblastoma, Clinicopathology, Histopathological typeAbstract
The emergence of ameloblastoma as the second most common odontogenic tumor that occurred after odontomas is a rare capacity to metastasize. Furthermore, this study aims to determine the clinicopathological profile of ameloblastoma. This was a descriptive retrospective study. The samples were obtained from histopathological examination data from the patients with ameloblastoma from January 2016 to December 2020 at the Anatomical Pathology Laboratory of Dr. Soetomo Academic General Hospital Surabaya. Moreover, the diagnosis of confirmed ameloblastoma was obtained in 95 cases. The occurrence age of ameloblastoma in both jaws ranged from 7-84 years with a mean age of 36.3 years. In this case, the highest number of patients with ameloblastoma has occurred in the 41-50 years age group with 21 cases (22%). There was no gender predilection in ameloblastoma. The most common location of ameloblastoma was found in the mandible which was confirmed in 82 cases (86%) and found in the maxilla for 13 cases (14%). In all, the most common type of ameloblastoma found was solid/multicystic ameloblastoma in 88 cases (93%) and unicystic ameloblastoma in 7 cases (7%).
Downloads
References
Cadavid AMH, Araujo JP, Coutinho-Camillo CM, Bologna S, Junior CAL and Lourenco SV. Ameloblastoma: current aspects of the new WHO classification in an analysis of 136 cases. Surgical and Experimental Pathology. 2019; 2: 17. Doi.org/10.1186/s42047-019-0041-z.
Evangelou Z, Zarachi A, Dumollard J.M, Peoc’h M, Komnos I, Kastanioudakis I, et al. Maxillary ameloblastoma: a review with clinical, histological and prognostic data of a rare tumor. In vivo. 2020; 34: 2249-2258. Doi:10.21873/invivo.12035.
Hariram, Mohammad S, Malkunje LR, Singh N, Das S, Mehta G. Ameloblastoma of the anterior mandible. Natl J Maxillofac Surg. 2014; 5: 47-50. Doi: 10.4103/0975-5950.140173.
Hendra FN, Cann EMV, Helder MN, Ruslin M, Visscher JGD, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: A systematic review and meta‐analysis. Oral Diseases. 2019; 1–10. Doi: 10.1111/odi.13031.
Hresko A, Burtyn O, Pavlovskiy L, Snisarevskyi P, Lapshyna J, Chepurnyi Y, et al. Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis. Med Oral Patol Oral Cir Bucal. 2021; Mar 1; 26 (2): e181-6. Doi:10.4317/medoral.24104.
Intapa C.Analysis of Prevalence and Clinical Features of Ameloblastoma and its Histopathological Subtypes in Southeast Myanmar and Lower Northern Thailand Populations: A 13-Year Retrospective Study. Journal of Clinical and Diagnostic Research 2017, Vol-11(1): ZC102-ZC106. Doi: 10.7860/JCDR/2017/23629.9295.
Khatri R, Divya KD, Jiwane AY, Gulati S, Balan A, Nileena RK, et al. Ameloblastoma: a 5 year retrospective analysis of cases in a tertiary healthcare center in kerala. Internasional journal of medical and applied sciences. 2015; 4(1): 207-214. E-ISSN:2320-3137.
Milman T, Ying G, Pan W, LiVolsi V. Ameloblastoma: 25 Year Experience at a Single Institution. Head and Neck Pathol 2016, 10: 513–520. Doi 10.1007/s12105-016-0734-5.
Neville BW, Allen CM, Damm DD, Chi AC. Oral and Maxillofacial pathology fourth edition. Elsevier; 2016. pp. 653-661.
Patsa S, Jadav RB, Halder GC, Ray JG, Datta S, Deb T. Demographic and histopathological variation of ameloblastoma: A hospital-based study. J Oral Maxillofac Pathol. 2016; 20: 230-3. Doi: 10.4103/0973-029X.185937.
Siar CH, Lau CH, Lau SH. Ameloblastoma of the Jaws: A Retrospective Analysis of 340 Cases in a Malaysian Population. J Oral Maxillofac Surg. 2012; 70: 608-615. Doi: 10.1016/j.joms.2011.02.039.
Vered M, Muller S, Heikinheimo K. WHO classification of Ameloblasoma 4th edition. IARC Press; 2017. pp. 215-216.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
